[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Pages 47202-47203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17946]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee, Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act 5 U.S.C. App. 2, that a meeting of the 
Genomic Medicine Program Advisory Committee (the Committee) will be 
held virtually on Wednesday, September 29, 2021. The meeting will begin 
at 11:30 a.m. EDT and adjourn at 3:30 p.m. EDT. The meeting is open to 
the public via Webex https://veteransaffairs.webex.com/veteransaffairs/j.php?MTID=m6736a5cdd10c19acb461d7de4d05eec6 password: n4XHwEk9y$8 or 
by phone at call-in +14043971596, meeting code: 1990514106##.
    The Committee's purpose is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care for Veterans and enhance the 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    On September 29, 2021, the Committee will receive updated briefings 
on various VA research programs, including the Million Veteran Program 
(MVP), to ascertain the program's progress in the areas of participant 
recruitment, data generation and storage, and data access. The 
Committee will also receive updates from ongoing MVP research, 
including a collaboration with the Department of Energy on suicide 
genetics, an update on precision oncology, and the VA Data Commons 
framework. Additionally, the Committee will discuss and explore 
potential recommendations for the next annual report.
    Public comments will be received at 3:00 p.m. EDT and are limited 
to 5 minutes each. Individuals who speak are invited to submit a 1-2 
page summary of their comments for inclusion in the official meeting 
record to Jennifer Moser, Designated Federal Officer, Office of 
Research and Development (14RD), 810 Vermont Avenue NW, Washington, DC 
20420, or at [email protected]. In the communication, writers must 
identify themselves and state the organization, association, or 
person(s) they represent. Any member of the public who wishes to attend 
the teleconference should RSVP to Jennifer Moser at 202-510-4253 no 
later than close of business, September 23, 2021, at the phone number 
or email address noted above.


[[Page 47203]]


    Dated: August 17, 2021.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-17946 Filed 8-20-21; 8:45 am]
BILLING CODE P